|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cirrhosis | |||||
| Liver Cirrhosis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Fibrosis | |||||
| 3 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| Liver Diseases | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| colchicine | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antimitotic Agents | |||||
| Antineoplastic Agents | |||||
| Antirheumatic Agents | |||||
| Gout Suppressants | |||||
| Mitosis Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| Tubulin Modulators | |||||
| 6 | Sponsors listed in this trial | ||||
| National Center for Research Resources (NCRR) | |||||
| The Children's Hospital, Denver | |||||